What is the Buying Price of Hester Biosciences Share?

The Buying Price of Hester Biosciences share is 2009.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

How to buy Hester Biosciences Share at Choice?

To buy Hester Biosciences stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Hester Biosciences, choose your preferred order type, and place the trade.

What is the PE ratio of Hester Biosciences Shares?

The Price-to-earnings (P/E) ratio of Hester Biosciences shares is 30.43. You can compare it with the sector average for relative valuation.

What is the PB ratio of Hester Biosciences Shares?

The Price to Book (P/B) ratio Hester Biosciences shares is 4.7. Useful to assess the stock's value relative to its book value.

Is Hester Biosciences Overvalued?

To assess Hester Biosciences’s valuation compare Sector P/E, P/B which are 55.51 & 3.01 with sector averages, along with growth rates and financial metrics.

What is the Market Cap of Hester Biosciences?

The Market Cap of Hester Biosciences is 1709.20 CR. It indicates the company's size category and trading liquidity.

What is the 52 Week High and Low of Hester Biosciences Share Price?

The 52 week high and low prices of Hester Biosciences share price is 2350 & 1239.3. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Which sector does Hester Biosciences belong to?

Hester Biosciences belongs to the Healthcare sector.

Hester Biosciences Share price

HESTERBIO

Healthcare Small Cap

2009.2

19.20 (0.96%)

NSE

BSE

Last updated on 29 May, 2026 | 15:49 IST

BUYSELL

Today's High

2078.90

Today's Low

1978.00

52 Week Low

1239.30

52 Week High

2350.00

Free Demat with Zero AMC*

Hester Biosciences Chart

ChartIQ

TradingView

Hester Biosciences Share Key Metrics

Volume

19894.00

Market Cap

1709.20 CR

LTQ@LTP

5@2009.20

ATP

2033.59

Var Margin

20.93 %

Circuit Range

1592-2388

Delivery %

36.76 %

Value

4.05 CR

ASM/GSM

No

Market Lot

1

Summary

29 May, 2026 | 15:49 को, Hester Biosciences का शेयर प्राइस आज ₹2009.2 पर है, जो दिन के लिए 19.20% की 0.96 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹1978.00 और ₹2078.90 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹1239.30 से ₹2350.00 तक रही है। ट्रेडिंग गतिविधि के मामले में, Hester Biosciences ने 19894 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹8506865 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹203359 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 5,200920 रही। यह स्टॉक ₹1592-2388 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹4.05 CR है। दिन के लिए डिलीवरी परसेंटेज 36.76% रही। इसके अतिरिक्त, Hester Biosciences वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Hester Biosciences Fundamentals

P/E Ratio

30.43

P/B Ratio

4.7

Div. Yield

0.55

Sector P/E

55.51

Sector P/B

3.01

Sec. Div. Yield

0.55

Hester Biosciences Resistance and Support

Pivot 2047.3

Resistance

First Resistance

2121.9

Second Resistance

2253.8

Third Resistance

2328.4

Support

First Support

1915.4

Second Support

1840.8

Third Support

1708.9

Hester Biosciences Shareholding Pattern

2016-17
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

53.73%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0.38%

Domestic Institutional Investors

0%

Retail

45.89%

Others

0%

Total Promoters

MAR '26

53.73%

Hester Biosciences Corporate Actions

Date	Agenda
2026-05-15	Audited Results & Final Dividend
2026-01-30	Quarterly Results

Hester Biosciences News

Hester Biosciences Limited

Hester Biosciences Africa's loan from Gates Foundation was restructured, reducing the outstanding amount from USD 12 million to USD 5 million and waiving all accrued interest. This amendment is expected to improve the subsidiary's liquidity and debt servicing.

May 20 2026 16:01:06

Hester Biosciences Ltd - 524669 - Announcement Under Regulation 30 Of Listing Regulations - Disclosure On Amendments In Loan Agreement Of Hester Africa

Hester Biosciences' subsidiary, Hester Africa, restructured its loan from Gates Foundation. The outstanding debt was reduced from USD 12 million to USD 5 million, with accrued interest waived and no further interest charged, significantly improving liquidity.

May 20 2026 16:01:00

Hester Biosciences Ltd - 524669 - Intimation Of Submission Of The Reclassification Application Under Regulation 31A Of Listing Regulations

Hester Biosciences submitted an application seeking "No Objection" from BSE and NSE for the reclassification of Mr. Ravin Gandhi and Ms. Bela Gandhi from the promoter to the public shareholding category. This is in accordance with Regulation 31A of SEBI (LODR) Regulations.

May 20 2026 10:52:36

Hester Biosciences Ltd - 524669 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Hester Bio's Q4 FY26 consolidated revenue increased by 22% and PAT surged 174%. The company's Poultry Healthcare division recorded 41% growth and secured licensing for the H9N2 Avian Influenza vaccine. Net debt reduced to Rs.70 crore, lowering debt-to-equity to 0.19 times, reflecting improved financial health.

May 18 2026 09:45:07

Hester Biosciences Ltd - 524669 - Announcement Under Regulation 30 (LODR) - Corporate Presentation

Hester Biosciences released its Corporate Presentation for FY26. The presentation highlights strong financial growth with consolidated net profit increasing by 99% to Rs.57.48 crore and consolidated revenue rising by 7% to Rs.332.60 crore.

May 15 2026 17:03:24

Hester Biosciences Ltd - 524669 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Hester Biosciences informed that the audio recording of its earnings conference call for the financial results of Q4 FY26 is now available on the company website for investor access.

May 15 2026 16:27:29

Hester Biosciences Ltd - 524669 - Disclosure On Board Approval For Re-Classification Request Under Regulation 31A Of SEBI Listing Regulations

Hester Biosciences board approved the request for re-classification of promoters Mr. Ravin Gandhi and Ms. Bela Gandhi to the 'public' shareholder category. This re-classification is contingent upon receiving a No Objection Certificate from the stock exchanges.

May 15 2026 12:25:03

Hester Biosciences Ltd - 524669 - Intimation Of Receipt Of Requests For Reclassification From The 'Promoters' To The 'Public' Category In Accordance With Regulation 31A Of SEBI Listing Regulations

Hester Biosciences received requests from two promoters, Mr. Ravin Gandhi (4.74% stake) and Ms. Bela Gandhi (4.71% stake), for reclassification of their shareholdings from 'Promoter' to 'Public' category. This formalizes their passive investment status and lack of management involvement.

May 15 2026 12:22:12

Hester Biosciences Ltd - 524669 - Announcement under Regulation 30 (LODR)-Change in Management

Hester Biosciences re-appointed Ms. Priya Gandhi as Executive Director for a three-year term, effective October 28, 2026. She is the daughter of CEO & MD Rajiv Gandhi and has been instrumental in driving the company's strategic direction.

May 15 2026 12:08:15

Hester Biosciences Ltd - 524669 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Hester Biosciences reported strong Q4 FY26 consolidated results, with revenue growing 22% YoY and net profit soaring 974% YoY to INR 165.46 million. The board also recommended a dividend of INR 11 per equity share for FY26.

May 15 2026 12:03:15

Name	Position
Bhupendra Gandhi	Chairman
Rajiv Gandhi	Managing Director & Chief Executive Officer

Hester Biosciences Similar Stocks

Sai Parenteral's Ltd.

485.90

1.15 (0.24%)

Indoco Remedies Ltd.

209.66

5.66 (2.77%)

Shalby Ltd.

168.81

-3.52 (2.04%)

Sakar Healthcare Ltd.

796.50

8.25 (1.05%)

Krsnaa Diagnostics Ltd.

549.45

11.00 (2.04%)

Windlas Biotech Ltd.

833.10

13.40 (1.63%)

NGL Fine-Chem Ltd.

2785.10

87.50 (3.24%)

Venus Remedies Ltd.

1280.05

60.95 (5.00%)

Amrutanjan Health Care Ltd.

558.65

-1.30 (0.23%)

Beta Drugs Ltd.

1429.50

-12.50 (0.87%)

Hester Biosciences FAQs

Hester Biosciences शेयर का खरीद मूल्य 2009.2 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Hester Biosciences शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Hester Biosciences शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 30.43 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Hester Biosciences शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 4.7 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Hester Biosciences शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.01 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Hester Biosciences का मार्केट कैप 1709.20 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Hester Biosciences शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 2350.00 और 1239.30 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।